Federica Perrone

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Journal: Tumori
Published: June 24, 2026

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Journal: Endocrine
Published: February 21, 2026

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Journal: Pediatric blood & cancer
Published: January 16, 2026

Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels.

Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 20, 2025

Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Journal: JCO precision oncology
Published: September 26, 2025

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Journal: Tumori
Published: July 10, 2025

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Journal: JCO precision oncology
Published: June 11, 2025

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Journal: Oncotarget
Published: June 10, 2025

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Journal: Frontiers in oncology
Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open
Published: May 16, 2025

Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" Trial.

Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" Trial.

Journal: European journal of cancer (Oxford, England : 1990)
Published: March 20, 2025

Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?

Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?

Journal: Tumori
Published: September 23, 2024
Showing 1-12 of 124

Last Updated: 09/26/2026